Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Horwitz

Showing results (11-20 of 510) with videos related to

Pageof 51
Sort By:
Cancer Treatment and Research|January 1, 1994
Hormone 'resistance' in breast cancer: the role of normal and mutant steroid receptorsK B Horwitz
Nature|February 17, 1994
How to make taxol from scratchS B Horwitz
Endocrine Reviews|May 1, 1992
The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer?K B Horwitz
Journal of Steroid Biochemistry|January 1, 1987
The structure and function of progesterone receptors in breast cancerK B Horwitz
Annals of the New York Academy of Sciences|June 11, 1993
Can hormone "resistant" breast cancer cells be inappropriately stimulated by tamoxifen?K B Horwitz
Breast Cancer Research : BCR|March 16, 2001
Bringing estrogen receptors under controlK B Horwitz
Seminars in Oncology|April 1, 1988
The central role of progesterone receptors and progestational agents in the management and treatment of breast cancerK B Horwitz
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1994
How do breast cancers become hormone resistant?K B Horwitz
Breast Cancer Research and Treatment|January 1, 1993
Mechanisms of hormone resistance in breast cancerK B Horwitz
Endocrinology|June 1, 1985
The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cellsK B Horwitz
Pageof 51

Showing results (11-20 of 510) with videos related to

Sort By:
Pageof 51
Cancer Treatment and Research|January 1, 1994
Hormone 'resistance' in breast cancer: the role of normal and mutant steroid receptorsK B Horwitz
Nature|February 17, 1994
How to make taxol from scratchS B Horwitz
Endocrine Reviews|May 1, 1992
The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer?K B Horwitz
Journal of Steroid Biochemistry|January 1, 1987
The structure and function of progesterone receptors in breast cancerK B Horwitz
Annals of the New York Academy of Sciences|June 11, 1993
Can hormone "resistant" breast cancer cells be inappropriately stimulated by tamoxifen?K B Horwitz
Breast Cancer Research : BCR|March 16, 2001
Bringing estrogen receptors under controlK B Horwitz
Seminars in Oncology|April 1, 1988
The central role of progesterone receptors and progestational agents in the management and treatment of breast cancerK B Horwitz
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1994
How do breast cancers become hormone resistant?K B Horwitz
Breast Cancer Research and Treatment|January 1, 1993
Mechanisms of hormone resistance in breast cancerK B Horwitz
Endocrinology|June 1, 1985
The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cellsK B Horwitz
Pageof 51